Bank Of New York Mellon Corp Nemaura Medical Inc. Transaction History

Bank Of New York Mellon Corp

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2020 Feb 09, 2021	SELL	$3.47 - $4.52 $2,751 - $3,584	-793 Reduced 4.93%	15,280 $57,000
Q2 2020 Aug 12, 2020	BUY	$4.75 - $15.38 $76,346 - $247,202	16,073 New	16,073 $148,000

Ticker NMRD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,102,900
Description
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.